These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of 18F-FDG PET/CT for diagnosis of vascular graft infection with spread to sternum caused by Coxiella burnetii. Dutasta F, Richaud C, Michon A, Ragone E, Podglajen I, Mainardi JL. Infect Dis (Lond); 2016 Oct; 48(10):769-71. PubMed ID: 27356964 [No Abstract] [Full Text] [Related]
7. FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis. Cheng CY, Huang WS, Shen DH, Fan YM, Hsu HH, Cherng SC, Lee SC. Clin Nucl Med; 2007 Feb; 32(2):117-21. PubMed ID: 17242565 [No Abstract] [Full Text] [Related]
8. (18)F-FDG PET/CT imaging in systemic lupus erythematosus related autoimmune haemolytic anaemia and lymphadenopathy. Zhang X, Xu C, Wang X. Hell J Nucl Med; 2016 Feb; 19(1):42-5. PubMed ID: 26929939 [Abstract] [Full Text] [Related]
9. The role of PET/CT in diagnosing generalized lymphadenopathy in asymptomatic secondary syphilis. Kim JM, Lee SM, Bae SB, Lee JS, Kim SY. Hell J Nucl Med; 2016 Feb; 19(1):60-2. PubMed ID: 26929943 [Abstract] [Full Text] [Related]
10. 18F-FDG-PET/CT in diagnosis of Q fever endocarditis. Domingues CM, Ferreira MJ, Silva R, Gonçalves V, Silva AM, Gonçalves L. J Nucl Cardiol; 2020 Aug; 27(4):1407-1411. PubMed ID: 31119713 [No Abstract] [Full Text] [Related]
11. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests. Ouyang L, Shi ZY, Lin ZG. Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185 [Abstract] [Full Text] [Related]
12. Bone marrow involvement in Q fever--detection by fluorine-18-labelled fluorodeoxyglucose PET. Alwis L, Balan K, Wright P, Lever A, Carmichael A. Lancet Infect Dis; 2009 Nov; 9(11):718. PubMed ID: 19850230 [No Abstract] [Full Text] [Related]
13. Dual-time point whole-body 18F-fluorodeoxyglucose PET/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB. Maturu VN, Agarwal R, Aggarwal AN, Mittal BR, Bal A, Gupta N, Gupta D. Chest; 2014 Dec; 146(6):e216-e220. PubMed ID: 25451368 [No Abstract] [Full Text] [Related]
14. [The usefulness of FDG-PET in patients with cervical lymphadenopathy]. Chang P, Liu HC, Tian JH, Yao SL, Wang T. Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):449-51. PubMed ID: 15854311 [Abstract] [Full Text] [Related]
15. Ovarian cancer, diagnosed with PET, with bilateral inguinal lymphadenopathy as primary presenting sign. Manci N, Bellati F, Graziano M, Pernice M, Muzii L, Angioli R, Benedetti Panici P. Gynecol Oncol; 2006 Mar; 100(3):621-2. PubMed ID: 16246401 [Abstract] [Full Text] [Related]
19. Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis. Seldin DW, Habib I, Soudry G. Clin Nucl Med; 2007 Jul; 32(7):524-6. PubMed ID: 17581335 [Abstract] [Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS). Rao VK, Carrasquillo JA, Dale JK, Bacharach SL, Whatley M, Dugan F, Tretler J, Fleisher T, Puck JM, Wilson W, Jaffe ES, Avila N, Chen CC, Straus SE. Am J Hematol; 2006 Feb; 81(2):81-5. PubMed ID: 16432855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]